99% up by HPLC Molnupiravir 2349386-89-4

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:99% up by HPLC Molnupiravir 2349386-89-4
CAS No.:2349386-89-4
Standard:USP, BP, EP, JP, In-house Standards
Price(USD):Negotiable
Company:Sinoway Industrial Co.Ltd.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Xiamen, Fujian

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East

  • Monthly Production Capacity: 1000kg

    Packaging Information: 25kg/drum 1kg/bottle

  • Delivery Lead Time: 7 days after payment

    Sample Provided: yes

    Payment Terms: L/L

    Product name

    Molnupiravir / EIDD-2801 / MK448

    CAS No.

    2349386-89-4

    Molecular Formula

    C13H19N3O7

    Molecular Weight

    329.31

    Quality Standard

    98% up by HPLC

    Appearance

    White powder

     

    COA of Molnupiravir

     

    ITEMS

    SPECIFICATION

    RESULT

    Appearance

    White to off-white powder

    White powder

    Solubility

    Sparingly soluble in methanol ,practically insoluble in water

    Complies

    Identity

    IR Spectrum of the test is concordant with the IR spectrum of the standard, obtained in the samemanner.

     

    Complies

    Related

    Substance

    Any single impurity not more than 0.1%

    0.04%

    Total impurities are not more than1.0%

    0.1%

     

    Limit of

    residual solvents

    2-propanol ≤ 5000ppm

    75 ppm

    Ethanol ≤ 5000ppm

    162 ppm

    Ethyl acetate ≤ 5000ppm

    Not detected

    Cyclohexane ≤ 3880ppm

    1 ppm

    Loss on drying

    ≤ 0.5%

    0.12%

    Residue on ignition

    ≤ 0.1%

    0.03%

    Heavy metals

    ≤ 0.02%

    Complies

    Assay

    98.0~102.0%

    99.5%

    Conclusion

    Complies with the specification

     

    Usage

     

    Function of Molnupiravir

    Molnupiravir / EIDD-2801 is an orally bioavailable prodrug of the ribonucleoside analog EIDD-1931. EIDD-2801 has broad-spectrum antiviral activity against influenza virus and multiple coronaviruses (e.g., SARS-ChemicalbookCoV-2, MERS-CoV, SARS-CoV). EIDD-2801 has the potential to treat the novel coronavirus COVID-19 as well as seasonal and pandemic influenza.

Send your message to this supplier
  • From:
  • To:
    Sinoway Industrial Co.Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service